Repligen to buy BioLife Solutions in $1.5 billion deal
22/07/2026 11:04
Repligen to buy BioLife Solutions in $1.5 billion deal July 22 (Reuters) - Repligen Corp RGEN.O said on Wednesday it would buy BioLife Solutions BLFS.O , a cell-and-gene-therapy tools maker, in a deal valued at about $1.5 billion to expand its presence in the fast-growing cell therapy market.
(Reporting by Sahil Pandey in Bengaluru; Editing by Tasim Zahid)
Recent news on Repligen
See all newsBrief: Repligen Announces $1 Billion Private Convertible Senior Notes Transaction
Repligen Corporation reports results for the quarter ended September 30 - Earnings Summary
Repligen Q3 revenue beats estimates on higher demand; lifts outlook
U.S. RESEARCH ROUNDUP-Autodesk, Hubspot, Oracle
Repligen Corp reports results for the quarter ended June 30 - Earnings Summary